Pharmacotherapy in Psychiatry and Neurology,
Journal Year:
2023,
Volume and Issue:
39(2), P. 187 - 201
Published: Jan. 1, 2023
AMA
Bidzan-Wiącek
M,
Bidzan
L.
Nutrition
and
cognitive
function
in
the
elderly
population.
Pharmacotherapy
Psychiatry
Neurology/Farmakoterapia
w
Psychiatrii
i
Neurologii.
2023;39(2):187-201.
doi:10.5114/fpn.2023.131059.
APA
Bidzan-Wiącek,
M.,
&
Bidzan,
(2023).
Neurologii,
39(2),
187-201.
https://doi.org/10.5114/fpn.2023.131059
Chicago
Monika,
Leszek
Bidzan.
2023.
"Nutrition
population".
Neurologii
39
(2):
Harvard
pp.187-201.
MLA
Monika
et
al.
population."
vol.
39,
no.
2,
2023,
pp.
Vancouver
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: Feb. 8, 2024
This
perspective
article
delves
into
the
implementation
of
Ketogenic
Metabolic
Therapy
(KMT)
by
a
mental
health
counselor
who
attempts
to
bridge
gap
between
emerging
research
and
real-world
clinical
application.
Grounded
in
author’s
experiences,
communicates
potential
KMT
care,
highlighting
both
its
therapeutic
promise
insights
gained
from
hands-on
patient
interactions.
While
adoption
necessitates
adjustments
societal,
emotional,
dietary
domains,
especially
within
diverse
contexts,
these
challenges
are
surmountable
with
appropriate
guidance
support.
The
encourages
capture
qualitative
data
alongside
quantitative
measures
advocates
for
an
approach
that
considers
broader
implications
improved
well-being
on
families
communities.
As
field
advances,
interdisciplinary
collaborations
researchers
clinicians
will
be
pivotal
refining
expanding
application
KMT,
ultimately
enhancing
outcomes
elevating
standard
care.
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: June 12, 2024
Our
core
premise
is
that
personalized
variations
of
a
ketogenic
diet
are
likely
to
benefit
pediatric
patients
with
neuropsychiatric
symptoms
across
multiple
domains.
Although
epilepsy
currently
well-accepted
indication
for
strict
diet,
there
dearth
knowledge
and
therefore
clinical
guidelines
upon
which
recommend
nutritional
ketosis
pervasive
conditions
such
as
autism
spectrum
disorder
ADHD,
even
when
comorbid
present.
However,
published
cohort
studies
current
trials
implementing
medical
therapies
cognitive
impairment,
psychiatric
comorbidities,
motor
disability,
neuroinflammation.
As
holistic
practitioners,
it
imperative
we
consider
the
health
child
in
its
entirety
-
additionally
offer
therapeutic
option
may
be
synergistic
treating
extra-neurologic
diseases
obesity.
While
uniquely
potential
adverse
side
effects
linear
growth
deceleration
micronutrient
deficiencies,
previous
our
center’s
experience
have
already
proven
low-risk
intervention
optimized
appropriate
patient
monitoring
support.
Expert Review of Neurotherapeutics,
Journal Year:
2023,
Volume and Issue:
23(10), P. 895 - 904
Published: Sept. 6, 2023
Epilepsy
is
often
accompanied
by
psychiatric
comorbidities
and
the
management
of
epilepsy
in
these
patients
presents
unique
challenges
due
to
interplay
between
underlying
neurological
condition
symptoms
combined
use
multiple
medications.This
paper
aims
explore
complexities
associated
with
managing
presence
comorbidities,
focusing
on
impact
disorders
treatment
strategies
posed
simultaneous
administration
medications.Patients
seem
present
a
more
severe
form
that
resistant
drug
treatments
burdened
an
increased
morbidity
mortality.
Whether
prompt
can
influence
long-term
prognosis
still
unclear
as
well
role
specific
strategies,
such
neuromodulation,
this
group
patients.
Clinical
practice
recommendations
guidelines
will
development
new
models
integrated
care
be
implemented.
Aging,
Journal Year:
2024,
Volume and Issue:
16(6), P. 4980 - 4999
Published: March 20, 2024
Background:
Modulated
by
differences
in
genetic
and
environmental
factors,
laboratory
mice
often
show
progressive
weight
gain,
eventually
leading
to
obesity
metabolic
dyshomeostasis.
Since
the
geroneuroprotector
CMS121
has
a
positive
effect
on
energy
metabolism
mouse
model
of
type
2
diabetes,
we
investigated
potential
counteract
changes
observed
during
ageing
process
wild
mice.
Methods:
Control
or
CMS121-containing
diets
were
supplied
ad
libitum
for
6
months,
sacrificed
at
age
7
months.
Blood,
adipose
tissue,
liver
analyzed
glucose,
lipids,
protein
markers
metabolism.
Results:
The
diet
induced
40%
decrease
body
gain
improved
both
glucose
lipid
indexes.
Lower
levels
hepatic
caspase
1,
3,
NOX4
with
indicating
lower
inflammatory
status.
Adipose
tissue
from
CMS121-treated
showed
increased
transcription
factors
Nrf1
TFAM,
as
well
mitochondrial
electron
transport
complexes,
GLUT4
higher
resting
rate.
Metabolomic
analysis
revealed
elevated
plasma
concentrations
short
chain
acylcarnitines
butyrate
metabolites
treated
CMS121.
Conclusions:
diminished
de
novo
lipogenesis,
which
is
associated
acetyl-CoA,
acylcarnitine,
metabolite
levels,
could
contribute
safeguarding
not
only
peripheral
system
but
also
aging
brain.
By
mimicking
effects
ketogenic
diets,
holds
promise
diseases
such
since
these
are
hard
follow
over
long
term.
Ketogenic
diets
(KDs)
have
shown
therapeutic
potential
for
a
range
of
neuropsychiatric
disorders;
however,
there
is
insufficient
data
regarding
the
behavioral
impacts
KDs
in
healthy
populations.
Here,
we
examined
impact
KD
on
sexual
behavior
young
adult
male
Sprague-Dawley
rats
maintained
either
or
standard
chow
diet
(SD).
We
found
that
males
exhibited
more
mounts
(across
all
four
sex
tests),
intromissions
(third
and
fourth
tests)
lower
ejaculation
likelihood
(second
test)
compared
to
SD
males.
These
results
suggest
reduced
reinforcing
properties
contact
necessary
achieve
Frontiers in Psychology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 26, 2024
Introduction
The
application
of
ketogenic
dietary
interventions
to
mental
health
treatments
is
increasingly
acknowledged
within
medical
and
psychiatric
fields,
yet
its
exploration
in
clinical
psychology
remains
limited.
This
article
discusses
the
potential
implications
diets,
traditionally
utilized
for
neurological
disorders,
broader
practices.
Methods
presents
a
perspective
based
on
existing
diet
research
historical
use,
biological
mechanisms,
therapeutic
benefits.
It
examines
these
diets
treatment
their
relevance
practice.
Results
review
informs
psychologists
benefits
introduces
literature
underlying
mechanisms
involved,
such
as
modulation
neurotransmitters,
reduction
inflammation,
stabilization
brain
energy
metabolism,
demonstrating
biopsychosocial
practice
psychology.
Conclusion
By
considering
metabolic
therapies,
can
broaden
scope
integration
provides
care
model
that
incorporates
knowledge
option
care.
emphasizes
need
further
training
support
effective
implementation
this
psychiatry
intervention.
British Journal of Neuroscience Nursing,
Journal Year:
2023,
Volume and Issue:
19(Sup4), P. S30 - S31
Published: July 2, 2023
George
Winter
discusses
the
extent
to
which
an
anti-inflammatory
ketogenic
diet
can
influence
progress
of
a
chronic
autoimmune
and/or
inflammatory
disease,
such
as
multiple
sclerosis.